IMARC Group’s report titled “Veterinary Infectious Disease Diagnostics Market Report by Technology (Immunodiagnostics, Molecular Diagnostics, and Others), Animal Type (Companion Animals, Food Producing Animals), Infection Type (Bacterial Infections, Viral Infections, Parasitic Infections, and Others), End User (Reference Laboratories, Veterinary Laboratories and Clinics, Point of Care/In House Testing, Research Institutes and Universities), and Region 2024-2032” , The global veterinary infectious disease diagnostics market size reached US$ 2.0 Billion in 2023. Looking forward, IMARC Group expects the market to reach US$ 4.0 Billion by 2032, exhibiting a growth rate (CAGR) of 7.4% during 2024-2032.
Factors Affecting the Growth of the Veterinary Infectious Disease Diagnostics Industry:
Rising Demand for Early Disease Detection:
The surge for timely disease detection is electrifying the veterinary diagnostics market. Pet lovers and livestock caretakers recognize the lurking threats of undiagnosed ailments. These hidden dangers can spell serious health issues or even tragic losses for our animals. In this climate of awareness, demand for swift and precise diagnostic tools is on the rise. Veterinary clinics and hospitals are harmonizing with the tune of preventive care. Spotlighting rapid diagnostics, these tools emerge as the unsung heroes. They safeguard our cherished pets, outsmarting looming health hurdles with finesse.Growing Use of Point-of-Care Diagnostics:
Point-of-care diagnostic tools are becoming more popular because they are convenient and easy to use.These portable wonder devices empower veterinarians to conduct tests on-site. Whether on a bustling farm or in a cozy clinic, results arrive in minutes. This is a game changer for rural and remote areas with few diagnostic labs. Thanks to tech advancements, like smartphone integration and cloud systems, efficiency soars. These innovations make diagnostics user-friendly and highly effective. Consequently, more veterinarians and animal health professionals embrace point-of-care testing.Advances in Molecular Diagnostics:
Modern molecular diagnostic tools are transforming the way animal diseases are detected. Molecular diagnostics revolutionize veterinary medicine. PCR and NGS pinpoint pathogens with unparalleled precision, unveiling novel and zoonotic diseases. These cutting-edge tools empower vets to diagnose accurately and craft tailored treatments. As practices increasingly adopt these technologies, animal healthcare reaps the benefits. Molecular techniques not only enhance disease detection but also pave the way for more effective interventions. Their growing prominence signals a new era in veterinary science, promising improved outcomes for our animal companions.
Grab a sample PDF of this report: https://www.imarcgroup.com/veterinary-infectious-disease-diagnostics-market/requestsample
Leading Companies Operating in the Global Veterinary Infectious Disease Diagnostics Industry:
Abbott Laboratories
Biomérieux SA
Creative Diagnostics
HESKA Corporation
Innovative Diagnostics
IDEXX Laboratories Inc.
Neogen Corporation
Qiagen N.V.
Randox Laboratories Ltd
Thermo Fisher Scientific Inc
Virbac., etc.
Veterinary Infectious Disease Diagnostics Market Report Segmentation:
Breakup by Technology:
Immunodiagnostics
Molecular Diagnostics
Others
Breakup by Animal Type:
Companion Animals
Food Producing Animals
Breakup by Infection Type:
Bacterial Infections
Viral Infections
Parasitic Infections
Others
Breakup by End User:
Reference Laboratories
Veterinary Laboratories and Clinics
Point of Care/In House Testing
Research Institutes and Universities
Regional Insights:
North America (United States, Canada)
Asia Pacific (China, Japan, India, South Korea, Australia, Indonesia, Others)
Europe (Germany, France, United Kingdom, Italy, Spain, Russia, Others)
Latin America (Brazil, Mexico, Others)
Middle East and Africa
Veterinary Infectious Disease Diagnostics Market Trends:
The veterinary infectious disease diagnostics market is on a thrilling updraft. Fueled by soaring investments in animal care and innovative technologies, it’s transforming before our eyes. By mid-2024, the surge in zoonotic diseases brought to light—quite starkly—their impact on public health. This urgency has spotlighted the pressing need for advanced diagnostic tools.
Note: If you need specific information that is not currently within the scope of the report, we will provide it to you as a part of the customization.
About Us
IMARC Group is a global management consulting firm that helps the world’s most ambitious changemakers to create a lasting impact. The company provide a comprehensive suite of market entry and expansion services. IMARC offerings include thorough market assessment, feasibility studies, company incorporation assistance, factory setup support, regulatory approvals and licensing navigation, branding, marketing and sales strategies, competitive landscape and benchmarking analyses, pricing and cost research, and procurement research.
Contact Us
IMARC Group
134 N 4th St. Brooklyn, NY 11249, USA
Email: sales@imarcgroup.com
Tel No:(D) +91 120 433 0800
United States: +1–631–791–1145
Write a comment ...